GlassScriptPhysician profile
Sushmita Veloor
NPI 1154391126
$1,796.13
in general payments reported to CMS, 2019-2025
25 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $287 · 2022: $145 · 2023: $56.31 · 2024: $165 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $421.45 | 2019-2020 | |
| Abbvie INC. | $267.36 | 2023-2025 | Botox |
| Kowa Pharmaceuticals America, INC. | $120.76 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.16 | 2019 | |
| Scilex Pharmaceuticals INC. | $109.37 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $109.35 | 2019 | |
| Tersera Therapeutics LLC | $82.50 | 2019 | |
| Pfizer INC. | $81.99 | 2019-2023 | |
| Amgen INC. | $78.14 | 2019 | |
| Daiichi Sankyo INC. | $64.59 | 2019 | |
| Collegium Pharmaceutical, INC. | $39.67 | 2019-2020 | |
| Medtronic, INC. | $38.88 | 2024 | Percept PC Brainsense |
| Saol Therapeutics INC. | $37.38 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $32.55 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $25.74 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sentynl Therapeutics, INC. | $25.53 | 2019 | |
| Corium, LLC | $23.87 | 2022 | |
| Emd Serono, INC. | $23.84 | 2020 | |
| Medtronic USA, INC. | $20.24 | 2019 | |
| Shionogi INC | $18.01 | 2019 | |
| Grt US Holding, INC. | $16.51 | 2020 | |
| Ucb, INC. | $16.05 | 2019 | |
| Zyla Life Sciences, INC. | $13.35 | 2019 | |
| Biodelivery Sciences International, INC. | $11.02 | 2019 | |
| Sumitomo Pharma America, INC. | $6.82 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sushmita Veloor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.